Edesa Biotech, Inc. (EDSA) Return on equity 2015–2021
Edesa Biotech, Inc. (EDSA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-102.2%FY2021 · since FY2015: -35.5% → -102.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -102.2% | -6.2 pp |
| FY2020 | -96.0% | — |
| FY2018 | -47.8% | +20.2 pp |
| FY2017 | -68.0% | -27.2 pp |
| FY2016 | -40.8% | -5.3 pp |
| FY2015 | -35.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice